Institutional investors purchased a net $3.5 million shares of INCY during the quarter ended June 2016 and now own 94.78% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 816.4 Thousand shares of Incyte Corp
SANDS CAPITAL MANAGEMENT LLC Bought 647.9 Thousand shares of Incyte Corp
MATRIX CAPITAL MANAGEMENT CO. LL... Bought 600.0 Thousand shares of Incyte Corp